A comprehensive prognostic and immunological implications of PFKP in pan-cancer
PFKP acts as an oncogene involved in tumorigenesis and may influence the immune microenvironment within the tumor. Our findings suggest that PFKP could serve as a potential biomarker for predicting prognosis and the efficacy of immunotherapy in tumors.
Authors
- Jianqun Ma (ORCID: https://orcid.org/0000-0002-7021-1298)
- Chengyuan Fang (ORCID: https://orcid.org/0000-0002-0878-5872)
- Luquan Zhang (ORCID: https://orcid.org/0000-0001-7681-2337)
- Xiaodong Ling (ORCID: https://orcid.org/0000-0001-8728-893X)
- Hao Liang (ORCID: https://orcid.org/0000-0002-3031-5121)
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1186/s12935-024-03497-w
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Harbin Medical University
- National Natural Science Foundation of China